Boc-D-N-Me-Phg-OH

Catalog No.: 
ACFHGL154
CAS No.: 
30925-12-3
Molecular Formula: 
C14H19NO4
Molecular Weight: 
265.31
Boc-D-N-Me-Phg-OH structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$92.00In stockIn stock
25g95%$432.00In stockIn stock
100g95%$1555.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBoc-D-N-Me-Phg-OH
IUPAC Name(R)-2-((tert-butoxycarbonyl)(methyl)amino)-2-phenylacetic acid
MDL No.MFCD07366768
Molecular FormulaC14H19NO4
Molecular Weight265.31
SMILESO=C(O)[C@H](N(C(OC(C)(C)C)=O)C)C1=CC=CC=C1
InChI KeyCOABPHLHHQAKPL-LLVKDONJSA-N
Synonymboc-d-n-me-phg-oh | 30925-12-3 | (2R)-2-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]-2-phenylacetic acid | Benzeneacetic acid, alpha-[[(1,1-dimethylethoxy)carbonyl]methylamino]-, (alphaR)- | N-Boc-(R)-a-(MethylaMino)-benzeneacetic acid | n-boc-n-methyl-d-phenyl
CAS No.30925-12-3
PubChem CID10901506

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACFHGL154 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXVPG437 route compound structure diagram
    ACXVPG43730925-14-5In Stock
  4. Then
  5. ACFHGL154 route product structure diagram
    ACFHGL15430925-12-3In Stock
Inquiry

2. ACFHGL154 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFHGL154 route product structure diagram
    ACFHGL15430925-12-3In Stock
Inquiry

3. ACFHGL154 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFHGL154 route product structure diagram
    ACFHGL15430925-12-3In Stock
Inquiry

Comments (0)